In this study, we isolated four bacterial strains grown on mitis-salivarius sucrose bacitracin agar. The strains had similar biochemical characteristics to biotypes I or II of mutans streptococci. The four isolates were identified as Streptococcus downei by 16S rDNA and dextranase gene (dex) sequencing as well as polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) targeting dex. To our knowledge, this is the first report of the isolation and identification of S. downei from dental plaque in humans. The results suggest that S. downei can inhabit the human oral cavity.
Introduction
Mutans streptococci (MS) are a group of oral cariogenic species which includes Streptococcus mutans, Streptococcus sobrinus, Streptococcus cricetus, Streptococcus rattus, Streptococcus downei, Streptococcus macacae, and possibly, Streptococcus ferus [1] . In this group of streptococci, S. mutans and S. sobrinus are the most frequently found in humans. S. downei was first isolated from the dental plaque of monkeys (Macaca fascicularis), initially designated as S. mutans serotype h [2] , and later reclassified as an independent species by biochemical tests, serotyping, and DNA-DNA hybridization [3] . Among the oral streptococci, S. downei is most closely related to S. sobrinus. S. downei strains were found to be cariogenic for germ-free rats given a high-sucrose diet, and were implicated in monkey caries [3] . Recently, while studying clinical strains of mutans streptococci isolated from dental plaques of the Korean population, we detected strains of S. downei. Since the isolation of S. downei from human dental plaque has not been reported previously, their identity was confirmed by use of the methods recently described by Igarashi et al. [4, 5] , which were based on mutans streptococci species-specific polymerase chain reaction. In this study, S. downei isolates were identified using 16S rDNA sequencing and S. downei-specific PCR methods. Biochemical tests were performed to determine the biotypes of S. downei strains, as described by Shklair and Keene [6, 7] . A phenol red broth base (BBL, Becton Dickinson Microbiology System, Cockeysville, MD, USA) was used as the basal medium for the fermentation of mannitol, sorbitol, raffinose, and melibiose. The carbohydrates were sterilized by Millipore filtration (0.22 lm pore size) and added aseptically to the warm basal media. The final concentration of the carbohydrates was 1.0%. The medium was dispensed into sterile screw cap tubes, which had previously been inoculated with the test organisms, and were read after 48 h of either aerobic (for all tubes of carbohydrates) or anaerobic (for the mannitol tube) incubation. In order to determine the production of ammonia generated from L-arginine, we used the appropriate medium, which was previously described by Niven, Jr., et al. [8] . After 48 h incubation, 0.1 ml of NesslerÕs reagent was added directly to the medium, and ammonia production was indicated by the development of an orange-yellow color. The biochemical tests were repeated with cultures of the reference strains to determine the reproducibility and reliability.
The identification of mutans streptococci at the species level was performed according to the method described by Igarashi et al. [4] . In brief, the PCR reaction was performed using an AccuPower Ò PCR PreMix (Bioneer Corp., Daejeon, Korea). The PCR primers were as follows: MSSD1467F (5 0 -TGT CGG WGC YRA YAT GAA AG-3 0 ) and MSSD2000R (5 0 -AAT ARR TTG GTT TGC TCR TC-3 0 ). The PCR products were purified using an AccuPrep Ò PCR Purification Kit (Bioneer Corp.) and then digested with a HaeIII (Bioneer Corp.) restriction enzyme. The HaeIII-digested DNA fragments were visualized after electrophoresis on a 4% NuSieve 3:1 agarose gel and stained with ethidium bromide. The length (bp) of the restriction fragments generated from the PCR products of mutans streptococci were as follows: 412 and 122 bp for S. mutans; 351 and 174 bp for S. sobrinus; 210, 174, and 141 bp for S. downei; 325 and 209 bp for S. rattus ; 210, 141, 109, and 65 bp for S. cricetus [4] .
Cloning and sequencing of 16S rDNA, as well as the dex gene, were performed to identify the clinical isolates at the species level. The bacterial genomic DNA was prepared using a G-spin ä Genomic DNA Extraction kit (iNtRON Co., Seoul, Korea) according to the manufacturerÕs instructions. In order to amplify the 16S rDNA or dex gene from the bacteria, a polymerase chain reaction (PCR) was performed with the primers 27F and 1492R [9] or Sd2864F (5 0 -CAA GAA CAG TCA GCG CCA GT-3 0 ) and Sd3670R (5 0 -AAG GGT CCT TGC CTG AAT CC-3 0 ) [5] , respectively. The PCR conditions were the same as described elsewhere [5, 9] . The PCR products were purified using an AccuPrep Ò PCR purification kit (Bioneer Corp.) and were directly ligated using the pGEM-T easy vector (Promega Corp., Madison, WI, USA). Nucleotide sequencing was performed using the dideoxy chain termination method with a Big Dye Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) and an ABI PRISM 310 Genetic Analyzer (Applied Biosystems). The ChDC-GEM-F (5 0 -TTC CCA GTC ACG ACG TTG TAA AA-3 0 ) and ChDC-GEM-R (5 0 -GTG TGG AAT TGT GAG CGG ATA AC-3 0 ) primers were used for the nucleotide sequencing of 16S rDNA and dex gene. The additional sequencing primers for 16S rDNA were as follows: Seq-F1 (5 0 -CCT ACG GGA GGC AGC AG-3 0 ), Seq-R2 (5 0 -GAC TAC CAG GGT ATC TAA TCC-3 0 ), and F16 (5-TAG ATA CCC YGG TAG TCC-3 0 ). All sequences were compared with a similar sequence of the reference organism by BLAST interrogation of the GenBank database (National Center for Biotechnology Information). 
Results and discussion
The PCR-RFLP profile resulting from the HaeIII-digested 525 bp fragment of dex genes revealed three subfragments (210, 174, and 141 bp) for each strains tested, and the restriction patterns turned out to be the same for both human and monkey S. downei isolates (Fig. 1) . The percent identity of the nucleotide sequences of the 16S rDNA of the four strains of human S. downei isolates with that of the S. downei-type strain (ATCC 33748 T ) was >98.9% (Table 1 and Fig. 2(A) ).
The data from PCR performed using S. downei-specific primers (Sd2864F and Sd3670R) showed that the species-specific PCR products were amplified from all four isolates, as well as from the type strain (Fig. 3) .
In order to confirm the specificity of the PCR, the amplicons of dex (807 bp) were cloned and sequenced; the data showed that the amplicons for the four isolates had either a 99.1% (ChDC YD1, YD2, and YD4) or 99.3% (ChDC YD2) identity with that of the type strain (Table 1 and Fig. 2(B) ).
The biotyping data showed that the four S. downei isolates were either biotype I or II, which are both quite unlike biotype VI of the type strain ( Table 2 ). The hydrolysis of arginine is of particular interest as this is a phenotypic characteristic previously restricted to S. rattus within the mutans streptococci. Although it is unclear why these phenotype differences exist, it is believed that they may be due to differences in the oral environments of hosts, e.g., eating habits. In conclusion, four strains of S. downei were isolated from the dental plaque of humans. To our knowledge, this is the first report of the isolation of this species from the human oral cavity, which implies that S. downei may somehow take part in the development of dental caries in humans. 
